1941 East Road

Nesreen S. Ibrahim, MD, is board-certified and fellowship-trained in psychiatry and child and adolescent psychiatry. She has extensive experience in several clinical areas of psychiatry, including autism, developmental delays, ADHD, mood, and psychotic disorders. Ibrahim is an assistant professor in the Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston, where she's passionate about teaching and mentoring medical students, residents, and fellows at all levels.She is also the medical director for Children's Memorial Hermann Hospital consult and liaison services. Ibrahim earned her medical degree from the University of Alexandria in 1995. She then completed a general psychiatry residency at The University of Texas Medical Branch in Galveston in 2006 and a child and adolescent psychiatry fellowship program at Allegheny Health Network in 2008. She is a delegate to the Harris County Medical Society Delegation to the Texas Medical Association House of Delegates. She's also an expert panelist on the Texas Medical Board.

Paul Schulz, M.D., is a professor of neurology at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). He received his combined BA-MD degrees from Boston University in 1984. He did a medical internship there, and moved to Baylor College of Medicine for his residency in Neurology. He stayed for a laboratory fellowship in cellular neurophysiology after which he became an assistant professor. Later, he was an associate professor of neurology, neuroscience, and translational biology and molecular medicine. Dr. Schulz was also the vice chair of education for neurology, the deputy chair of the Methodist neurology service, and directed the Cognitive Disorders Clinics at Baylor and the Houston Veterans Administration Hospital. Dementia Program In 2010, Dr. Schulz moved to Mischer Neuroscience Institute, where he sees patients who have cognitive, behavioral, or mood disorders. His group is investigating risk factors for dementia in order to understand why it develops, including both environmental and genetic factors. They use imaging, epidemiologic, and genetic approaches and have identified several risk factors. They are also investigating ways to diagnose dementia earlier, perhaps before symptoms develop, in order to determine whether interventions in the presymptomatic stage might delay or prevent the development of dementia. His group has early data suggesting that the treatment of some risk factors may reduce the probability of developing dementia. Dr. Schulz has received numerous awards and has been an invited speaker at major scientific meetings worldwide. He has been extensively published in the scientific literature and has been featured on television and radio shows.